Sino-Swed Pharmaceutical Corp Ltd. (SSPC) is the first joint venture between China and Sweden. In 1999, the foreign-held shares of SSPC were transferred to Fresenius Group. The company specializes in clinical nutrition and is the first company in China, which can export infusion products to the European market.